Investing in AI Research and Rare Disease Drug Development – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn:

“Benjamin L. Ebert President and CEO, shared his perspectives with Boston Business Journal on the institute’s planned investments in AI research and rare disease drug development while keeping plans for its new hospital on track in the new year.